ALVO OAKTREE ACQUISITION CORP II

Aðalfundur Alvotech boðaður 25. júní 2025

Aðalfundur Alvotech boðaður 25. júní 2025

Aðalfundur Alvotech verður haldinn miðvikudaginn 25. júní 2025, kl. 09.00 CEST á skrifstofu Arendt & Medernach að 41A Avenue John F. Kennedy, L-1855 Lúxemborg.

Dagskrá fundarins er að finna í meðfylgjandi viðhengi. Fundurinn fer fram á ensku.

Fundargögn og allar frekari upplýsingar varðandi aðalfundinn er hægt að nálgast á heimasíðu félagsins 

Nánari upplýsingar veitir:

Alvotech, fjárfestatengsl

Benedikt Stefánsson, forstöðumaður

Viðhengi



EN
26/05/2025

Underlying

ALVOOAKTREE ACQUISITION CORP II

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OAKTREE ACQUISITION CORP II

 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Reports Results for the First Six Months of 2025 and Provides...

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq Stockholm Market Conference call and live webcast on Thursday August 14, 2025, 8:00 am ET (12:00pm GMT) REYKJAVIK, Iceland, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “C...

19h / 53m 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Reports Results for the First Six Months of 2025 and Provides...

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flowsContinued expansion of commercial partnerships for pipeline assetsAlvotech listed on Nasdaq Stockholm MarketConference call and live webcast on Thursday August 14, 2025, 8:00 am ET (12:00pm GMT) REYKJAVIK, Iceland, August 13, 2025 - Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimil...

19h / 53m 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech birtir uppgjör fyrir fyrstu sex mánuði ársins og kynnir nýjus...

Alvotech birtir uppgjör fyrir fyrstu sex mánuði ársins og kynnir nýjustu áfanga í rekstri félagsins Yfir 200% aukning á tekjum af sölu lyfja á fyrri helmingi ársins miðað við sama tíma í fyrraAnnar ársfjórðungur sá besti í sögu félagsins hvað varðar handbært fé frá rekstri Nýir samningar um markaðsetningu endurspegla virði lyfja á fyrri stigum þróunarBréf Alvotech skráð á Nasdaq markaðinn í StokkhólmiKynning á uppgjörinu í beinu streymi fimmtudaginn 14. ágúst kl. 12 á hádegi (á ensku) REYKJAVIK, 13. ágúst 2025 - Alvotech (NASDAQ: ALVO) birtir í dag uppgjör fyrir fyrstu sex mánuði ársins og...

19h / 53m 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Announces Webcast to Report Financial Results for the First H...

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT REYKJAVIK, ICELAND (August 6, 2025) – Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first half of the year ended June 30, 2025, after U.S. markets close on Wednesday, August 13, 2025.  Alvotech will also conduct a conference call to present the financial results and recent business highlights on Thursday August 14, ...

August 6, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Announces Webcast to Report Financial Results for the First H...

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT REYKJAVIK, Iceland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first half of the year ended June 30, 2025, after U.S. markets close on Wednesday, August 13, 2025. Alvotech will also conduct a conference call to present the financial results and recent business highlights on Thu...

August 6, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch